Fludarabine

Adult T-Cell Leukemia/Lymphoma

John ReneauSmall moleculePhase 2Active

BBB

76/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 64/ 100
Competitive Position: 95/ 100

Competitive context

32 Active assets in the Adult T-Cell Leukemia/Lymphoma cohort.

Asset / Sponsor	Phase	Rating
Dexasone The First Affiliated Hospital of Soochow University	Phase 2	BBB
Cyclophosphamide John Reneau	Phase 4	BBB
Etoposide National Cancer Institute (NCI)	Phase 2	BBB
Rituximab Northwestern University	Phase 2	BBB
LENALIDOMIDE National Cancer Institute (NCI)	Phase 2	BBB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

Fanconi anemiaActive

BBB

Indicative · Phase 2/3

76 / 100

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BBB

Indicative · Phase 2

76 / 100

T-cell large granular lymphocyte leukemiaDormant

BBB

Indicative · Phase 2

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.